- Home
- CGTX vs MRCC Comparison
CGTX vs MRCC Comparison
Compare CGTX & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- MRCC
- Stock Information
- Founded
- CGTX 2007
- MRCC 2011
- Country
- CGTX United States
- MRCC United States
- Employees
- CGTX N/A
- MRCC N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- CGTX Health Care
- MRCC Finance
- Exchange
- CGTX Nasdaq
- MRCC Nasdaq
- Market Cap
- CGTX 158.8M
- MRCC 151.2M
- IPO Year
- CGTX 2021
- MRCC 2012
- Fundamental
- Price
- CGTX $1.66
- MRCC $6.58
- Analyst Decision
- CGTX Strong Buy
- MRCC Hold
- Analyst Count
- CGTX 3
- MRCC 1
- Target Price
- CGTX $2.83
- MRCC $8.00
- AVG Volume (30 Days)
- CGTX 1.3M
- MRCC 63.2K
- Earning Date
- CGTX 11-06-2025
- MRCC 11-05-2025
- Dividend Yield
- CGTX N/A
- MRCC 15.20%
- EPS Growth
- CGTX N/A
- MRCC N/A
- EPS
- CGTX N/A
- MRCC N/A
- Revenue
- CGTX N/A
- MRCC $43,742,000.00
- Revenue This Year
- CGTX N/A
- MRCC N/A
- Revenue Next Year
- CGTX N/A
- MRCC N/A
- P/E Ratio
- CGTX N/A
- MRCC N/A
- Revenue Growth
- CGTX N/A
- MRCC N/A
- 52 Week Low
- CGTX $0.22
- MRCC $5.96
- 52 Week High
- CGTX $3.83
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- CGTX 48.96
- MRCC 33.56
- Support Level
- CGTX $1.54
- MRCC $6.80
- Resistance Level
- CGTX $1.77
- MRCC $7.07
- Average True Range (ATR)
- CGTX 0.13
- MRCC 0.17
- MACD
- CGTX -0.01
- MRCC -0.02
- Stochastic Oscillator
- CGTX 31.49
- MRCC 27.67
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.